The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Interleukin-12 (IL-12) plays a key role in promoting T helper 1 (Th1) responses and subsequent cell-mediated immunity. Given the role of cytokines in the pathogenesis of psychiatric disorders, the dysregulation of IL-12 in these illnesses would be expected. We measured the plasma levels of IL-12 in 102 psychiatric patients (43 schizophrenia, 34 major depression and 25 bipolar disorder) and 85 normal controls. In addition, IL-12 levels of the patients were measured after an 8-week treatment to assess whether the levels were affected by medication. The IL-12 levels of the patient group with major depression were significantly higher than that of the control group, whereas no differences were found among the other groups. IL-12 values of the three patient groups decreased significantly after 8 weeks of treatment. These findings support the hypothesis that activation of the inflammatory response system and in particular of Th-1-like cells, is involved in the pathophysiology of major depression and that repeated administration of antidepressive and antipsychotic drugs may suppress IL-12 plasma concentrations in psychiatric patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated pro-inflammatory cytokines had been reported to be associated with greater symptom burden in BD (14, 15), and correlation between severity of affective symptoms and serum levels of IL-6, sIL-2R, sIL-6R, TNF-α and tumor necrosis factor receptor 60 and 80 kDa (sTNFR60/80) was found in several studies (16–21).”
From Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder? (2023) · cites this paper as [19]
In the citing paper
“there was a significant decrease in IL-12 plasma levels after eight weeks of antidepressant pharmacotherapy [118].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [118]
In the citing paper
“the plasma levels of IL-12 were significantly higher in patients with depression compared to controls”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [118]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., & Presky, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.495 · Cited by 1,231
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 482
Maes, M., Bosmans, E., Calabrese, J., Smith, R., & Meltzer, H. Y. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00049-w · Cited by 385
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Self-citation
Research works printed but not linked: 2
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn) American Psychiatric Press: Washington DC 1994
- First MB, Gibbon M, Spitzer RL, Williams JBW . Structural Clinical Interview for DSM-IV Research Version Biometric Research Department, New York Psychiatric Institute: New York 1998
Cited by
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Kim, Y.-K., Na, K.-S., Myint, A.-M., & Leonard, B. E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.008 · Cited by 620
“Rather, more complex neural mechanisms are thought to be involved in depression (Kim et al., 2002; Myint et al., 2007).”
BackgroundSelf-citationCytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.007 · Cited by 596
Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.014 · Cited by 544
Kynurenine pathway in major depression: Evidence of impaired neuroprotection
Myint, A.-M., Kim, Y. K., Verkerk, R., Scharpé, S., Steinbusch, H., & Leonard, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.013 · Cited by 527
“, 2005) and increased pro-inflammatory cytokines (Kaestner et al., 2005; Thomas et al., 2005; Mikova et al., 2001; Connor and Leonard, 1998; Anisman et al., 1999; Lanquillon et al., 2000; Myint et al., 2005; Kim et al., 2002) have been reported in patients with major depression.”
BackgroundSelf-citationThe role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
Na, K.-S., Jung, H.-Y., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.022 · Cited by 427
Self-citationCytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A. M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 374
Self-citationImbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Kim, Y.-K., Jung, H.-G., Myint, A.-M., Kim, H., & Park, S.-H. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.018 · Cited by 375
“018 play an integral role in the pathophysiology of certain psychiatric disorders, including depressive disorder (Kim et al., 2002; Leonard, 2000; Maes, 1995; Schiepers et al., 2005) and schizophrenia (Kim, 2005; Muller et al.”
BackgroundSelf-citationImmune and neuroendocrine mechanisms of stress vulnerability and resilience
Ménard, C., Pfau, M. L., Hodes, G. E., & Russo, S. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.90 · Cited by 374
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371
“Based on the macrophage theory of depression (Smith, 1991), circumstantial evidence was provided that major depression is associated with dysregulation of immune mediators, such as the rise in IL-1h, IL-6, IL-12, soluble IL-6R, IL-2, soluble IL-2R, IL-1Ra and IFN-g (Kim et al., 2002; Maes, 1994, Maes et al., 1992, 199…”
BackgroundSelf-citationLymphocytes as a neural probe: potential for studying psychiatric disorders
Gladkevich, A., Kauffman, H. F., & Korf, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.009 · Cited by 360
Cytokine imbalance in the pathophysiology of major depressive disorder
Kim, Y.-K., Na, K.-S., Shin, K.-H., Jung, H.-Y., Choi, S.-H., & Kim, J.-B. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.004 · Cited by 314
“Kim et al. / Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 (2007) 1044–1053”
BackgroundSelf-citationPro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315
Won, E., & Kim, Y.-K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151208113006 · Cited by 300
Self-citationSelected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
Drexhage, R. C., Knijff, E. M., Padmos, R. C., Heul-Nieuwenhuijzen, L. V. D., Beumer, W., Versnel, M. A., & Drexhage, H. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.144 · Cited by 263
Immune variations in bipolar disorder: phasic differences
Ortiz‐Domínguez, A., Hernández, M. E., Berlanga, C., Gutiérrez‐Mora, D., Moreno, J., Heinze, G., & Pavón, L. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00493.x · Cited by 255
Cytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
Raison, C. L., & Miller, A. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.2 · Cited by 253
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240
“Kim et al. (2002) found that IL-12 levels were initially increased in depressed patients, but decreased after 8 weeks of antidepressant treatment.”
BackgroundInflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease
Halaris, A. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_28 · Cited by 233
Kynurenines: from the perspective of major psychiatric disorders
Myint, A. M. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08551.x · Cited by 229
Serum and gene expression profile of cytokines in first-episode psychosis
Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K. J., Janiri, L., Murray, R. M., Dazzan, P., Pariante, C. M., & Mondelli, V. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.06.010 · Cited by 217
“…psychosis, reporting higher serum or plasma levels of IL-1b, IL-6, IL-12, INFc, TNF- a, TGF- b and soluble IL-2 receptor (Ganguli and Rabin, 1989; Kim et al., 2000, 2002, 2004, 2009; Theodoropoulou et al., 2001; Crespo-Facorro et al., 2008; Fernandez-Egea et al., 2009; Song et al., 2009).”
BackgroundNeuropsychiatric Disease and Toxoplasma gondii Infection
Henriquez, S. A., Brett, R., Alexander, J., Pratt, J., & Roberts, C. W. (2009) · Neuroimmunomodulation · doi:10.1159/000180267 · Cited by 206
Barden, N., Harvey, M., Gagné, B., Shink, E., Tremblay, M., Raymond, C., Labbé, M., Villeneuve, A., Rochette, D., Bordeleau, L., et al. (2006) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30303 · Cited by 202
Rowland, T., Perry, B. I., Upthegrove, R., Barnes, N., Chatterjee, J., Gallacher, D., & Marwaha, S. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.144 · Cited by 196
A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients
Sayana, P., Colpo, G. D., Simões, L. R., Giridharan, V. V., Teixeira, A. L., Quevedo, J., & Barichello, T. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.03.018 · Cited by 187
MRC ImmunoPsychiatry Consortium, Wittenberg, G. M., Stylianou, A., Zhang, Y., Sun, Y., Gupta, A., Jagannatha, P. S., Wang, D., Hsu, B., Curran, M. E., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0471-8 · Cited by 187
Richards, E. M., Zanotti-Fregonara, P., Fujita, M., Newman, L., Farmer, C., Ballard, E. D., Machado-Vieira, R., Yuan, P., Niciu, M. J., Lyoo, C. H., et al. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0401-9 · Cited by 180
Th1, Th2 and Th3 cytokine alteration in schizophrenia
Kim, Y.-K., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, H.-J., Kim, D.-J., & Leonard, B. E. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.047 · Cited by 187
“…IL-2 and TNF-a in schizophrenia showed controversial findings in different studies (Akiyama, 1999; Cazzullo et al., 2001; DeLisi, 1996; Ganguli et al., 1992; Gattaz et al., 1992; Kim et al., 2000, 2002; Maes et al., 1995; Naudin et al., 1997; O’Donnell et al., 1996; Theodoropoulou et al., 2001).”
ResultSelf-citationMaes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
“Another pro-inflammatory cytokine that is increased in depression (Kim et al., 2002) and that plays a role in CAD is IL-12.”
BackgroundSystematic Review of Proinflammatory Cytokines in Obsessive-Compulsive Disorder
Gray, S. M., & Bloch, M. H. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0272-0 · Cited by 162
Li, Y., Xiao, B., Qiu, W., Yang, L., Hu, B., Tian, X., & Yang, H. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.018 · Cited by 163
Baune, B. T., Stuart, M., Gilmour, A., Wersching, H., Heindel, W., Arolt, V, & Berger, K. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.18 · Cited by 157
“Several studies have demonstrated differences in immune parameters between lithium-treated patients and unmedicated patients,104,113,118 however, this effect is not always replicated.101,102,109,114 Any immune-modulatory effect appears to be related to chronic treatment with this agent and could not be replicated by i…”
ResultInfluentialNowak, W., Grendas, L. N., Sanmarco, L. M., Estecho, I. G., Arena, Á. R., Eberhardt, N., Rodante, D. E., Aoki, M. P., Daray, F. M., Carrera Silva, E. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.063 · Cited by 159
“(not included in meta-analysis) also found a significant increase of IL-12 levels in 34 patients with MDD compared with HC [45].”
ResultThe effects of vitamin B on the immune/cytokine network and their involvement in depression
Mikkelsen, K., Stojanovska, L., Prakash, M. D., & Apostolopoulos, V. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.11.012 · Cited by 168
Hope, S., Melle, I., Aukrust, P., Steen, N. E., Birkenaes, A. B., Lorentzen, S., Agartz, I., Ueland, T., & Andreassen, O. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00757.x · Cited by 152
“European, n (%) 242 (99) 255 (82) 142 (76) 113 (90) Creatinine (umol ⁄ l), mean (SD) 72 (11) 72 (15) 72 (13) 72 (17) ALAT (U ⁄ l), mean (SD) 25 (18) 28 (20) 29 (19) 27 (21) Diabetes ⁄ CVD, n (%) 0 (0) 14 (5) 9 (5) 5 (4) Alcohol use, mean (SD) 9 (10) 9 (19) 7 (17) 13 (23)”
Cytokines in Bipolar Disorder: Paving the Way for Neuroprogression
Barbosa, I. G., Bauer, M. E., Machado-Vieira, R., & Teixeira, A. L. (2014) · Neural Plasticity · doi:10.1155/2014/360481 · Cited by 147
“Several studies have also reported cognitive impairment along with structural (decrease of hippocampal and amygdala volumes and total gray matter) and neurophysiological changes [5– 9].”
BackgroundThe role of inflammatory cytokines in suicidal behavior: A systematic review
Serafini, G., Pompili, M., Elena Seretti, M., Stefani, H., Palermo, M., Coryell, W., & Girardi, P. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.06.002 · Cited by 151
“Also, immune abnormalities such as activation of the inflammatory response system, increased levels of proinflammatory cytokines, increases in prostaglandin E2 and negative immunoregulatory cytokines in peripheral blood are frequent in MDD (Maes, 1999; Kim et al., 2002; Leonard, 2001).”
BackgroundThe role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150
Self-citationAlterations in Immune Cells and Mediators in the Brain: It's Not Always Neuroinflammation!
Estes, M. L., & McAllister, A. K. (2014) · Brain Pathology · doi:10.1111/bpa.12198 · Cited by 142
Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
Anderson, G., & Maes, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660738 · Cited by 147
“IL-2 levels are enhanced in depression [277].”
Differences in cytokines between non-suicidal patients and suicidal patients in major depression
Kim, Y.-K., Lee, S.-W., Kim, S.-H., Shim, S.-H., Han, S.-W., Choi, S.-H., & Lee, B.-H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.041 · Cited by 140
“Kim et al. / Progress in Neuro-Psychopharmacology & Biological Psychiatry 32 (2008) 356–361”
BackgroundSelf-citationDepression and Immunity: Inflammation and Depressive Symptoms in Multiple Sclerosis
Gold, S. M., & Irwin, M. R. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.008 · Cited by 136
“One study also reported increased plasma levels of IL-12 in a large cohort of depressed patients [33].”
BackgroundPoletti, S., Vai, B., Mazza, M. G., Zanardi, R., Lorenzi, C., Calesella, F., Cazzetta, S., Branchi, I., Colombo, C., Furlan, R., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110136 · Cited by 127
Leonard, B. E. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.018 · Cited by 129
Kim, Y. K. (2003) · Journal of the Korean Medical Association · doi:10.5124/jkma.2003.46.9.783 · Cited by 125
Self-citationThe role of neuroinflammation on pathogenesis of affective disorders
Rhie, S. J., Jung, E.-Y., & Shim, I. (2020) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2040016.008 · Cited by 126
“In the clinical study, the increase in plasma concentrations of the pro-inflammatory cytokines observed in patients suffering from depression is known to be closely correlated with the severity of this psychiatric disorder, the hyperactivity of the hypothalamicpituitary-adrenal (HPA) axis and the deficiency in seroton…”
BackgroundThe putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 133
“IL-12 Human studies Human studies " Levels in depressed patients (Kim et al., 2002; Sutcigil et al., 2007) " Levels in AD patients (Guerreiro et al.”
Diamond, M., Kelly, J. P., & Connor, T. J. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.11.011 · Cited by 141
Immune System Dysregulation in First-Onset Postpartum Psychosis
Bergink, V., Burgerhout, K. M., Weigelt, K., Pop, V. J. M., de Wit, H., Drexhage, R. C., Kushner, S. A., & Drexhage, H. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.006 · Cited by 131
Bai, Y., Su, T., Tsai, S., Chiou, W., Li, C., Tu, P., & Mu-Hong, C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.009 · Cited by 131
“Furthermore, psychiatric medications (Kim et al., 2002; Kim et al., 2004; Guloksuz et al., 2010; Hope et al., 2011) and smoking (Szlagatys-Sidorkiewicz et al.”
BackgroundNoto, C., Maes, M., Ota, V. K., Teixeira, A. L., Bressan, R. A., Gadelha, A., & Brietzke, E. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1062552 · Cited by 116
Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma
Little, R. F., Pluda, J. M., Wyvill, K. M., Rodriguez-Chavez, I. R., Tosato, G., Catanzaro, A. T., Steinberg, S. M., & Yarchoan, R. (2006) · Blood · doi:10.1182/blood-2005-11-4455 · Cited by 114
Altamura, A. C., Buoli, M., & Pozzoli, S. M. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12089 · Cited by 118
“In this light, preliminary findings indicate that atypical antipsychotics may reverse immuno-inflammatory abnormalities at the same time with the improvement of clinical symptoms.(85,163,164) Interestingly, a recent paper showed that quetiapine treatment was associated with a parallel improvement of positive symptoms…”
BackgroundCytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment
Reale, M., Costantini, E., & Greig, N. H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.536257 · Cited by 96
GSK-3 mediates differentiation and activation of proinflammatory dendritic cells
Rodionova, E., Conzelmann, M., Maraskovsky, E., Hess, M., Kirsch, M., Giese, T., Ho, A. D., Zöller, M., Dreger, P., & Luft, T. (2007) · Blood · doi:10.1182/blood-2006-06-028951 · Cited by 108
Psychological stress and depression: risk factors for IBD
Bernstein, C. N. (2016) · Digestive Diseases · doi:10.1159/000442929 · Cited by 107
The role of the kynurenine metabolism in major depression
Myint, A.-M., Schwarz, M., & Müller, N. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0741-3 · Cited by 125
The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view
Müller, N., & Schwarz, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_33 · Cited by 117
Medina-Rodriguez, E. M., Lowell, J. A., Worthen, R. J., Syed, S. A., & Beurel, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00547 · Cited by 101
“, 2009), whereas other cytokines, such as sIL-2R, CCL2, IL-13, IL-18, and IL-12, have been found to be elevated in the blood of MDD patients in a few studies (Maes, 1995; Kim et al., 2002; Merendino et al., 2002; Pavón et al., 2006; Köhler et al., 2017).”
BackgroundPsychosocial Burden and Other Impacts of Rosacea on Patients’ Quality of Life
Oussedik, E., Bourcier, M., & Tan, J. K. L. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2017.11.005 · Cited by 109
The role of the cytokine network in psychological stress
Kim, Y.-K., & Maes, M. (2003) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2003.00026.x · Cited by 102
Self-citationT-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.
Kim, Y.-K., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, S.-W., Leonard, B. E., & Steinbusch, H. W. M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.08.005 · Cited by 100
“, 2001), and bipolar disorder (Maes et al., 1995a; Rapaport et al., 1999; Tsai et al., 1999, 2001; Kim et al., 2002; Su et al., 2002).”
Self-citationApplications of blood-based protein biomarker strategies in the study of psychiatric disorders
Chan, M. K., Gottschalk, M. G., Haenisch, F., Tomasik, J., Ruland, T., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.08.002 · Cited by 101
Soczynska, J. K., Kennedy, S. H., Goldstein, B. I., Lachowski, A. M., Woldeyohannes, H. O., & McIntyre, R. S. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.03.004 · Cited by 103
O’Brien, S. M., Scully, P., & Dinan, T. G. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.014 · Cited by 100
The cytokine network in the pathogenesis of major depressive disorder. Close to translation?
Petralia, M. C., Mazzon, E., Fagone, P., Basile, M. S., Lenzo, V., Quattropani, M. C., Di Nuovo, S., Bendtzen, K., & Nicoletti, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102504 · Cited by 84
Rush, G., O’Donovan, A., Nagle, L., Conway, C., McCrohan, A., O’Farrelly, C., Lucey, J. V., & Malone, K. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.035 · Cited by 86
Brambilla, P., Bellani, M., Isola, M., Bergami, A., Marinelli, V, Dusi, N., Rambaldelli, G., Tansella, M., Maria Finardi, A., Martino, G., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.46 · Cited by 86
Does escitalopram reduce neurotoxicity in major depression?
Halaris, A., Myint, A.-M., Savant, V., Meresh, E., Lim, E., Guillemin, G., Hoppensteadt, D., Fareed, J., & Sinacore, J. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.04.026 · Cited by 86
“Increases in pro-inflammatory cytokines and an imbalance between pro- and anti-inflammatory cytokines in depression have been well documented in the literature (Anisman et al., 1999; Connor and Leonard, 1998; Kaestner et al., 2005; Kim et al., 2002; Lanquillon et al., 2000; Mikova et al., 2001; Thomas et al., 2005; My…”
BackgroundAnderson, G., Maes, M. H. J., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.016 · Cited by 99
“IL‐12, which is produced by many immune cells and stimulates the production of IFNγ as well as the activation and differentiation of naïve T cells, is increased in clinical depression (Kim et al., 2002).”
BackgroundMonocytic, Th1 and Th2 Cytokine Alterations in the Pathophysiology of Schizophrenia
Na, K.-S., & Kim, Y.-K. (2007) · Neuropsychobiology · doi:10.1159/000111535 · Cited by 82
Self-citationJacoby, A. S., Munkholm, K., Vinberg, M., Pedersen, B. K., & Kessing, L. V. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.040 · Cited by 85
Inflammatory Markers Among Adolescents and Young Adults With Bipolar Spectrum Disorders
Goldstein, B. I., Lotrich, F., Axelson, D. A., Gill, M. K., Hower, H., Goldstein, T. R., Fan, J., Yen, S., Diler, R., Dickstein, D., et al. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09395 · Cited by 77
Depression and Immunity: Inflammation and Depressive Symptoms in Multiple Sclerosis
Gold, S. M., & Irwin, M. R. (2006) · Neurologic Clinics · doi:10.1016/j.ncl.2006.03.007 · Cited by 82
Tryptophan Metabolism and Immunogenetics in Major Depression: A Role for Interferon-γ Gene
Myint, A. M., Bondy, B., Baghai, T. C., Eser, D., Nothdurfter, C., Schüle, C., Zill, P., Müller, N., Rupprecht, R., & Schwarz, M. J. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.003 · Cited by 74
“Both increased pro-inflammatory cytokines (Anisman et al., 1999; Connor and Leonard, 1998; Kaestner et al., 2005; Kim et al., 2002; Lanquillon et al., 2000; Mikova et al., 2001; Myint et al., 2005; Thomas et al., 2005) and hypercortisolaemia (Asnis et al., 1981a,b; Cohen et al., 1984; Lin et al.,…”
BackgroundÇelik, C., Erdem, M., Çaycı, T., Özdemir, B. H., Akgül, E. Ö., Kurt, Y. G., Yaman, H., Isıntas, M., Özgen, F., & Özşahin, A. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.002 · Cited by 77
Immune and Neuroimmune Alterations in Mood Disorders and Schizophrenia
Drexhage, R. C., Weigelt, K., van Beveren, N., Cohen, D., Versnel, M. A., Nolen, W. A., & Drexhage, H. A. (2011) · International Review of Neurobiology · doi:10.1016/b978-0-12-387718-5.00007-9 · Cited by 71
Kim, H. K., Chen, W., & Andreazza, A. C. (2015) · Neural Plasticity · doi:10.1155/2015/408136 · Cited by 81
Self-citationPeripheral immune markers and antipsychotic non-response in psychosis
Enache, D., Nikkheslat, N., Fathalla, D., Morgan, B. P., Lewis, S. W., Drake, R., Deakin, J. F. W., Walters, J., Lawrie, S. M., Egerton, A., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.020 · Cited by 71
“IL12p70 is secreted mainly by macrophages and plays a key role in activating type 1 T helper (Th1) cells and inducing the production of IFN-γ in the natural killer cells (Kim et al., 2002).”
The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review
van den Ameele, S., van Diermen, L., Staels, W., Coppens, V., Dumont, G. J. H., Sabbe, B., & Morrens, M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.016 · Cited by 73
Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder
Pfaffenseller, B., Fries, G. R., Wollenhaupt-Aguiar, B., Colpo, G. D., Stertz, L., Panizzutti, B., Magalhães, P. V., & Kapczinski, F. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811981 · Cited by 68
UFRGS-UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL
Saúde, B. D., & Pós-Graduação, P. R. D. (2009) · Cited by 68
The influence of inflammatory cytokines in physiopathology of suicidal behavior
Miná, V. A. L., Lacerda-Pinheiro, S. D. F., Maia, L. C., Pinheiro, R. F. F., Meireles, C. B., de Souza, S. I. R., Reis, A. O. A., Bianco, B. A. V., & Rolim, M. L. N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.057 · Cited by 70
“Lower IFN-γ and IL-4 together with higher TGF-β1 were observed in both MDD groups.”
BackgroundInfluentialIsgren, A., Jakobsson, J., Pålsson, E., Ekman, C. J., Johansson, A. G. M., Sellgren, C. M., Blennow, K., Zetterberg, H., & Landén, M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.10.001 · Cited by 73
“Some studies report no association between cytokine/ cytokine receptor concentrations and medication status (Barbosa et al., 2011; Drexhage et al., 2011; Söderlund et al., 2011), while others have found significant associations (Hope et al., 2011; Kim et al., 2002, 2004).”
2D-DIGE proteome analysis on the platelet proteins of patients with major depression
Huang, T., Sung, M.-L., & Chen, T. (2014) · Proteome Science · doi:10.1186/1477-5956-12-1 · Cited by 71
“CAD are IL-12 [24], IL-1 type, IL-8 [25], IL-2, IL-6 and TNF-α [26,27].”
Claes, S., Myint, A.-M., Domschke, K., Del-Favero, J., Entrich, K., Engelborghs, S., De Deyn, P., Mueller, N., Baune, B., & Rothermundt, M. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.03.012 · Cited by 65
Higher Baseline Interleukin-1β and TNF-α Hamper Antidepressant Response in Major Depressive Disorder
Benedetti, F., Poletti, S., Vai, B., Mazza, M. G., Lorenzi, C., Brioschi, S., Aggio, V., Branchi, I., Colombo, C., Furlan, R., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.009 · Cited by 62
Molecular Neurobiology and Promising New Treatment in Depression
Jeon, S. R., & Kim, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030381 · Cited by 72
“, (2002) [57] Various antidepressant 8 ÓIL-12 Lee and Kim (2006) [58] Various antidepressant 6 ÓIL-12, ÒTGF-β Sutcigil et al.”
BackgroundSelf-citationEthyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression
Murck, H., Song, C., Horrobin, D. F., & Uhr, M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004249 · Cited by 57
Crespo‐Facorro, B., Carrasco-Marín, E., Pérez‐Iglesias, R., Pelayo‐Terán, J. M., Fernández-Prieto, L., Leyva‐Cobián, F., & Vázquez‐Barquero, J. L. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2006.08.005 · Cited by 63
“In contrast, they described a decrease in plasma IL-12 values after 8 weeks of antipsychotic treatment (using a variety of antipsychotics) in a sample of 29 schizophrenic patients, including drug-naïve andmedication-free individuals (Kim et al., 2002).”
BackgroundResultInfluentialPsychobiology of depression/distress in congestive heart failure
York, K. M., Hassan, M., & Sheps, D. S. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9091-0 · Cited by 58
The use of ustekinumab in autoimmune disease
Ryan, C., Thrash, B., Warren, R. B., & Menter, A. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712591003724670 · Cited by 57
“There is also, however, an increase of IL-12 levels in those with major depression, which normalizes with treatment [37].”
Background
Metadata
- Authors
- Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J.
- Affiliations
- Korea University Ansan Hospital (KR)
- Korea University (KR)
- Yongin Mental Hospital (KR)
- University of California, Los Angeles (US)
- Corresponding author
- Kim, H
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 2002-12-01
- Volume
- 7
- Issue
- 10
- Pages
- 1107-1114
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1992868687
- Cited by
- 224
- References
- 62
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 7 · 2020: 16 · 2019: 8 · 2018: 5 · 2017: 9 · 2016: 17 · 2015: 14 · 2014: 12 · 2013: 9 · 2012: 19
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- IL-12, schizophrenia, major depressive disorder, bipolar mania, psychotropic drugs, antidepressants, antipsychotic drugs, cytokines, Th1 response, plasma cytokines
- MeSH terms
- Adolescent, Adult, Aged, Bipolar Disorder, Depressive Disorder, Female, Humans, Male, Middle Aged, Psychotropic Drugs, Reference Values, Schizophrenia, Th1 Cells, Interleukin-12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.